Table 2.
Tolerability of Mycophenolate and Azathioprine
| Variable | Complete Cohort (N = 70) | MMF (n = 51) | AZA (n = 19) |
|---|---|---|---|
| Reported side effects, No. (%) | 10 (14.3) | 7 (13.7) | 3 (15.8) |
| Nausea | 3 (4.3) | 3 (5.8) | 0 |
| Diarrhea | 2 (2.9) | 1 (1.9) | 1 (5.3) |
| Transaminitis | 2 (2.9) | 1 (1.9) | 1 (5.3) |
| GI upset | 1 (1.4) | 1 (1.9) | 0 |
| Bloating | 1 (1.4) | 1 (1.9) | 0 |
| Fatigue | 1 (1.4) | 0 | 1 (5.3) |
| Management of side effect, No. (%) | |||
| Dose reduction | 3 (4.3) | 3 (5.8) | 0 |
| Drug discontinuation | 2 (2.9) | 2 (5.8) | 2 (10.5) |
See Table 1 legend for expansion of abbreviations.